Meeting
2019 Gastrointestinal Cancers Symposium
Significance of monitoring plasma vascular endothelial growth factor signals during treatment of colorectal cancer patients.
Authors
Nao Kakizawa
Saitama Mediacl Center, Jichi Medical University, Saitama, Japan
Nao Kakizawa , Koichi Suzuki , Hideki Ishikawa , Fumiaki Watanabe , Fumi Hasegawa , Rina Kikugawa , Shingo Tsujinaka , Kazushige Futsuhara , Yasuyuki Miyakura , Toshiki Rikiyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 577)
DOI
10.1200/JCO.2019.37.4_suppl.577
Abstract #
577
Poster Bd #
G20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical development and evaluation of plasma angiogenesis factors from phase II study of FOLFIRI plus ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin/fluoropyrimidine (RAINCLOUD): RAINCLOUD-TR.
First Author: Tsuyoshi Hata
Poster
2020 ASCO Virtual Scientific Program
NIVACOR: Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab in first-line chemotherapy for advanced colorectal cancer RASm/BRAFm patients.
First Author: Angela Damato
Poster
2022 ASCO Annual Meeting
Analysis of plasma angiogenesis factors on the efficacy of first-line (1L) chemotherapy (chemo) combined with biologics in RAS wild-type metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study.
First Author: Satoshi Yuki
Poster
2022 ASCO Annual Meeting
A new prognostic model in patients with recurrent or metastatic head and neck cancer treated with chemotherapy: An analysis of ECOG-ACRIN E1305.
First Author: Athanassios Argiris